发布求助
文献互助 智能选刊 最新文献

Australian Prescriber最新文献

筛选
英文 中文
Latest News: Herpes zoster (shingles) vaccination update 最新消息：带状疱疹疫苗接种最新情况
IF 2.7
Australian Prescriber Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.027
{"title":"Latest News: Herpes zoster (shingles) vaccination update","authors":"","doi":"10.18773/austprescr.2023.027","DOIUrl":"https://doi.org/10.18773/austprescr.2023.027","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"44 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139009819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gabapentinoids: a therapeutic review 加巴喷丁类药物：治疗综述
IF 2.7
Australian Prescriber Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.025
Akshay Athavale, B. Murnion
{"title":"Gabapentinoids: a therapeutic review","authors":"Akshay Athavale, B. Murnion","doi":"10.18773/austprescr.2023.025","DOIUrl":"https://doi.org/10.18773/austprescr.2023.025","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"18 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139010104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Drug: Tirzepatide for type 2 diabetes 新药：治疗 2 型糖尿病的替氮帕肽
IF 2.7
Australian Prescriber Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.028
{"title":"New Drug: Tirzepatide for type 2 diabetes","authors":"","doi":"10.18773/austprescr.2023.028","DOIUrl":"https://doi.org/10.18773/austprescr.2023.028","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"57 4","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139007195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Top 10 drugs 2021–22 2021-22 年十大药物
IF 2.7
Australian Prescriber Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.029
{"title":"Top 10 drugs 2021–22","authors":"","doi":"10.18773/austprescr.2023.029","DOIUrl":"https://doi.org/10.18773/austprescr.2023.029","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"7 26","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138977186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Drug: Vericiguat for chronic heart failure 新药：治疗慢性心力衰竭的威利吉特
IF 2.7
Australian Prescriber Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.031
{"title":"New Drug: Vericiguat for chronic heart failure","authors":"","doi":"10.18773/austprescr.2023.031","DOIUrl":"https://doi.org/10.18773/austprescr.2023.031","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"40 21","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139008767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood glucose monitoring devices: current considerations 血糖监测设备:当前的考虑
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.013
Benjamin Sly, Janet Taylor
{"title":"Blood glucose monitoring devices: current considerations","authors":"Benjamin Sly, Janet Taylor","doi":"10.18773/austprescr.2023.013","DOIUrl":"https://doi.org/10.18773/austprescr.2023.013","url":null,"abstract":"SUMMARY Measuring blood glucose concentrations via capillary (fingerprick) blood glucose monitoring or continuous (interstitial) glucose monitoring is an important aspect of management for many people with diabetes. Blood glucose monitoring informs patient self-management strategies, which can improve the patient’s engagement in their own care and reduce barriers to achieving recommended blood glucose targets. Blood glucose monitoring also informs clinician-guided management plans. Compared to capillary blood glucose monitoring, continuous glucose monitoring in people using insulin significantly improves glycaemic metrics and is associated with improved patient-reported outcomes. Even with good glycaemic metrics, patients using continuous glucose monitoring should still have access to capillary blood glucose monitoring for correlation of hypoglycaemic readings when accuracy may be compromised or if there is a malfunction with the continuous blood glucose monitor.","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"91 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Drug: Tozinameran+riltozinameran and tozinameran+famtozinameran for prevention of COVID-19 新药:Tozinameran+riltozinameran和Tozinameran+ famtozinameran用于预防COVID-19
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.019
{"title":"New Drug: Tozinameran+riltozinameran and tozinameran+famtozinameran for prevention of COVID-19","authors":"","doi":"10.18773/austprescr.2023.019","DOIUrl":"https://doi.org/10.18773/austprescr.2023.019","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"53 34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of menopause 更年期的管理
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.014
Karen Magraith, Christina Jang
{"title":"Management of menopause","authors":"Karen Magraith, Christina Jang","doi":"10.18773/austprescr.2023.014","DOIUrl":"https://doi.org/10.18773/austprescr.2023.014","url":null,"abstract":"SUMMARY During perimenopause and after menopause, women may experience diverse symptoms. All women require a comprehensive assessment of their current health and risks for future disease, appropriate screening, and promotion of a healthy lifestyle. Menopausal hormone therapy is the most effective treatment for menopausal symptoms. It can be offered to symptomatic patients with no contraindications following an individualised discussion about the risk of harms versus benefits. Menopausal hormone therapy is recommended for women with premature ovarian insufficiency (menopause occurring before 40 years of age) regardless of symptoms, unless contraindicated. Nonhormonal medications may improve symptoms for women who have contraindications to, or do not wish to take, menopausal hormone therapy.","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Drug: Elasomeran+davesomeran for prevention of COVID-19 预防COVID-19的新药:Elasomeran+davesomeran
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.018
{"title":"New Drug: Elasomeran+davesomeran for prevention of COVID-19","authors":"","doi":"10.18773/austprescr.2023.018","DOIUrl":"https://doi.org/10.18773/austprescr.2023.018","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"61 11","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccines in 2023 2023年的COVID-19疫苗
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.020
Ketaki Sharma, Jean Li-Kim-Moy
{"title":"COVID-19 vaccines in 2023","authors":"Ketaki Sharma, Jean Li-Kim-Moy","doi":"10.18773/austprescr.2023.020","DOIUrl":"https://doi.org/10.18773/austprescr.2023.020","url":null,"abstract":"SUMMARY Most Australian adults now have hybrid immunity to the SARS-CoV-2 virus, referring to a combination of protection from previous vaccine doses and past infection. Protection from both vaccination and past infection wanes over time. Booster doses are recommended to ensure that those who are at increased risk of severe COVID-19 remain protected. The optimal timing of future booster doses to maintain adequate protection against severe illness is not yet known. Older age remains the most important risk factor for severe COVID-19, including in the current Omicron variant era. The original COVID-19 vaccines are monovalent vaccines based on the ancestral strain of the SARS-CoV-2 virus. Bivalent vaccines have been developed based on earlier Omicron subvariants (BA.1 or BA.4-5) and the ancestral strain. These provide enhanced protection against severe illness from Omicron compared with the original monovalent vaccines. Updated monovalent vaccines based on a more recent Omicron subvariant (XBB.1.5) have been developed. COVID-19 vaccines have an excellent safety record, and serious adverse events are extremely rare.","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"39 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信